Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
97.816,96
-0,30%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Nexalin Technologies Inc (NXLIW) Nexalin Technologies Inc (NXLIW) Notizie

Nexalin Technologies Inc

NXLIW
0,42
0,00 (0,00%)
03 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202416:00GLOBENexalin Technology Completes Phase 1of its Innovative..
20/12/202418:35EDGAR2Form S-1 - General form for registration of securities under..
26/11/202416:00GLOBENew Peer-Reviewed Publication Validates Nexalin’s Deep..
11/11/202414:00GLOBENexalin Technology CEO Provides Letter to Shareholders
08/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202419:31EDGAR2Form 8-K - Current report
01/11/202419:00GLOBEJoin Nexalin Technology’s Exclusive Live Investor Webinar..
01/11/202415:34GLOBENexalin Technology Regains Compliance with Nasdaq Continued..
30/10/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202413:30GLOBENexalin Technology Announces Landmark Study on Alzheimer's..
22/10/202420:15GLOBENexalin Technology Announces Planned Clinical Trial..
17/10/202414:30GLOBENew Study Shows Nexalin’s Deep Intracranial Frequency..
14/10/202414:30GLOBENexalin Technology Appoints Carolyn Shelton as Senior Vice..
02/10/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202422:31EDGAR2Form 8-K - Current report
05/9/202415:00GLOBENexalin Technology Participates in Congressional Roundtable..
18/7/202414:30GLOBENexalin Technology Selected to Join Industry Coalition: ..
01/7/202420:45GLOBENexalin Technology Announces Closing of $5.2 Million Public..
28/6/202403:15GLOBENexalin Technology Announces Pricing of $5.2 Million Public..
26/6/202415:00GLOBENexalin Technology Announces Positive Clinical Study Data in..
20/6/202414:30GLOBENexalin Technology Awarded Key Patent Related to its..
18/6/202423:02EDGAR2Form 8-K - Current report
14/6/202415:53EDGAR2Form S-1/A - General form for registration of securities..
13/6/202421:00GLOBENexalin Technology Announces Regulatory Approval to Sell..
12/6/202419:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202414:30GLOBENexalin Technology to Present at the Spring MicroCap Rodeo..
03/6/202414:30GLOBEFDA Provides Feedback and Reaches Consensus on Nexalin’s..
23/5/202423:17EDGAR2Form S-1 - General form for registration of securities under..
22/5/202414:30GLOBENexalin America Selected to Join the National Traumatic..
21/5/202422:39EDGAR2Form 8-K - Current report
14/5/202422:54EDGAR2Form RW - Registration Withdrawal Request
10/5/202420:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:30GLOBEJoin Nexalin Technology’s Exclusive Live Investor Webinar..
25/4/202416:44GLOBENexalin Technology Regains Compliance with Nasdaq Continued..
09/4/202414:30GLOBENexalin Technology Accelerates Manufacturing of its HALO™..
04/4/202419:00GLOBENexalin Technology Awarded Key Patent Related to its Gen-3..
02/4/202414:30GLOBENexalin Technology Announces the Appointment of Government..
28/3/202413:30GLOBENexalin Technology Announces Positive Results of Clinical..
14/3/202413:30GLOBENexalin Technology Commences Sales of Gen-2 Neurostimulation..
13/3/202413:30GLOBENexalin Technology Announces Poster Presentation at “State..
08/2/202414:30GLOBENexalin Technology Announces Regulatory Approval in Oman for..
23/1/202414:30GLOBENexalin Technology Awarded Key Patent Related to its..
11/1/202414:30GLOBENexalin Technology Unveils Next-Generation HALO™ Clarity
Apertura: Min: Max:
Chiusura: 0,42

La tua Cronologia

NASDAQ
NXLIW
Nexalin Technologies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network